Informatie:
Fout:
ID
34329
Beschrijving
Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection; ODM derived from: https://clinicaltrials.gov/show/NCT01147107
Link
https://clinicaltrials.gov/show/NCT01147107
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C, Chronic NCT01147107
Eligibility Hepatitis C, Chronic NCT01147107
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01147107
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
hiv infected patients, age >18 years, meet vietnam guideline to begin art (cd4 count < 350 cells/mm3 and/or who stage iii or iv disease)
boolean
ID.2
Item
hepatitis c infection as documented by positive hcv antibodies and a detectable serum hcv rna level
boolean
ID.3
Item
ast and alt ≤ 2 x uln (≤ 80 u/l)
boolean
ID.4
Item
estimated creatinine clearance ≥ 60 ml/min
boolean
ID.5
Item
any prior art
boolean
ID.6
Item
positive hepatitis b surface antigen
boolean
ID.7
Item
clinical evidence of de-compensated cirrhosis (ascites, encephalopathy, esophageal bleeding)
boolean
ID.8
Item
requirement for acute therapy for other aids-defining illness within 14 days prior to study entry
boolean
ID.9
Item
currently on rifampicin therapy
boolean
ID.10
Item
in the first trimester of pregnancy, intent to become pregnant, or breast feeding during the study period
boolean